Complete Up To Date Information about Spectramast™ LC Sterile Suspension.
NADA Number: 141-238 | |
| Proprietary Name |
Spectramast™ LC Sterile Suspension |
|---|---|
| Sponsor |
Pharmacia & Upjohn Co. |
| Sponsor Address |
a Division of Pfizer, Inc. 235 East 42nd St. New York, NY 10017 USA |
| Ingredients |
Ceftiofur Hydrochloride |
| Species |
Cattle, dairy, lactating |
| Routes of Administration |
Intramammary |
| Dose Form |
Liquid (suspension) |
| Drug Form |
Liquid (suspension) |
| Dispensing Status |
RX |
| Patent Number |
4902683 |
| Exclusivity |
Granted for the use of cefiotfur hydrochloride for the treatment of clinical mastitis in lactating dairy cattle associated with coagulase-negative staphylococci, Streptococcus dysgalactiae, and Escherichia coli. |
| Withdrawal Time |
Milk: 72 hours
Cattle: 2 days |
|
Dosage Amount, Indications & Limitations |
526.313 Ceftiofur. Specifications Each single-use, 10-milliliter syringe of ceftiofur hydrochloride suspension contains 125 milligrams (mg) ceftiofur equivalents. Conditions of use: Lactating dairy cattle Amount: Infuse 125 mg per affected quarter. Repeat treatment in 24 hours. Once daily treatment may be repeated for up to 8 consecutive days. Indications: For the treatment of clinical mastitis in lactating dairy cattle associated with coagulase-negative staphylococci, Streptococcus dysgalactiae, and Escherichia coli. Limitations: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Milk taken from cows during treatment (a maximum of eight daily infusions) and for 72 hours after the last treatment must not be used for human consumption. Following label use for up to eight consecutive days, a 2-day pre-slaughter withdrawal period is required. |
| Tolerances |
A tolerance for residues of ceftiofur in edible tissue of poultry and sheep is not required. Tolerances in swine for desfuroylceftiofur (marker residue) in edible swine tissues are 0.25 part per million in kidney (target tissue), 3 parts per million in liver, and 2 parts per million in muscle. Tolerances are established for residues of desfuroylceftiofur (marker residue) in edible cattle tissues at 0.4 parts per million in kidney (target tissue), 2 parts per million in the liver, 1 part per million in muscle, 100 parts per billion in milk. |